Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Healthcare CRO Services Market, by Service Type
1.4.2 LAMEA Healthcare CRO Services Market, by End User
1.4.3 LAMEA Healthcare CRO Services Market, by Therapeutic Area
1.4.4 LAMEA Healthcare CRO Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Aug – 2020, Mar) Leading Players
Chapter 4. LAMEA Healthcare CRO Services Market by Service Type
4.1 LAMEA Clinical Research Services Market by Country
4.2 LAMEA Early Phase Development Market by Country
4.3 LAMEA Laboratory Services Market by Country
4.4 LAMEA Consulting Services Market by Country
Chapter 5. LAMEA Healthcare CRO Services Market by End User
5.1 LAMEA Pharmaceutical Sector Market by Country
5.2 LAMEA Medical Device Sector Market by Country
5.3 LAMEA Academic Institutes Market by Country
Chapter 6. LAMEA Healthcare CRO Services Market by Therapeutic Areas
6.1 LAMEA Oncology Market by Country
6.2 LAMEA CNS Disorder Market by Country
6.3 LAMEA Cardiovascular Disease Market by Country
6.4 LAMEA Diabetes Market by Country
6.5 LAMEA Metabolic Diseases Market by Country
6.6 LAMEA Infectious Diseases Market by Country
6.7 LAMEA Other therapeutic areas Market by Country
Chapter 7. LAMEA Healthcare CRO Services Market by Country
7.1 Brazil Healthcare CRO Services Market
7.1.1 Brazil Healthcare CRO Services Market by Service Type
7.1.2 Brazil Healthcare CRO Services Market by End User
7.1.3 Brazil Healthcare CRO Services Market by Therapeutic Area
7.2 Argentina Healthcare CRO Services Market
7.2.1 Argentina Healthcare CRO Services Market by Service Type
7.2.2 Argentina Healthcare CRO Services Market by End User
7.2.3 Argentina Healthcare CRO Services Market by Therapeutic Area
7.3 UAE Healthcare CRO Services Market
7.3.1 UAE Healthcare CRO Services Market by Service Type
7.3.2 UAE Healthcare CRO Services Market by End User
7.3.3 UAE Healthcare CRO Services Market by Therapeutic Area
7.4 Saudi Arabia Healthcare CRO Services Market
7.4.1 Saudi Arabia Healthcare CRO Services Market by Service Type
7.4.2 Saudi Arabia Healthcare CRO Services Market by End User
7.4.3 Saudi Arabia Healthcare CRO Services Market by Therapeutic Area
7.5 South Africa Healthcare CRO Services Market
7.5.1 South Africa Healthcare CRO Services Market by Service Type
7.5.2 South Africa Healthcare CRO Services Market by End User
7.5.3 South Africa Healthcare CRO Services Market by Therapeutic Area
7.6 Nigeria Healthcare CRO Services Market
7.6.1 Nigeria Healthcare CRO Services Market by Service Type
7.6.2 Nigeria Healthcare CRO Services Market by End User
7.6.3 Nigeria Healthcare CRO Services Market by Therapeutic Area
7.7 Rest of LAMEA Healthcare CRO Services Market
7.7.1 Rest of LAMEA Healthcare CRO Services Market by Service Type
7.7.2 Rest of LAMEA Healthcare CRO Services Market by End User
7.7.3 Rest of LAMEA Healthcare CRO Services Market by Therapeutic Area
Chapter 8. Company Profiles
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 